These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38674259)

  • 21. Follow-Up After Myocardial Infarction to Explore the Stability of Arrhythmogenic Substrate: The Footprint Study.
    Jáuregui B; Soto-Iglesias D; Penela D; Acosta J; Fernández-Armenta J; Linhart M; Terés C; Syrovnev V; Zaraket F; Hervàs V; Prat-González S; Perea RJ; Morales-Ruiz M; Jiménez W; Lasalvia L; Bosch X; Ortiz-Pérez JT; Berruezo A
    JACC Clin Electrophysiol; 2020 Feb; 6(2):207-218. PubMed ID: 32081225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic Resonance in Transthyretin Cardiac Amyloidosis.
    Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Zumbo G; Knight DS; Kotecha T; Francis R; Hutt DF; Rezk T; Rosmini S; Quarta CC; Whelan CJ; Kellman P; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    J Am Coll Cardiol; 2017 Jul; 70(4):466-477. PubMed ID: 28728692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis.
    Cavalcante JL; Rijal S; Abdelkarim I; Althouse AD; Sharbaugh MS; Fridman Y; Soman P; Forman DE; Schindler JT; Gleason TG; Lee JS; Schelbert EB
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):98. PubMed ID: 29212513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extent of peri-infarct scar on late gadolinium enhancement cardiac magnetic resonance imaging and outcome in patients with ischemic cardiomyopathy.
    Tülümen E; Rudic B; Ringlage H; Hohneck A; Röger S; Liebe V; Kuschyk J; Overhoff D; Budjan J; Akin I; Borggrefe M; Papavassiliu T
    Heart Rhythm; 2021 Jun; 18(6):954-961. PubMed ID: 33515714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.
    Knight DS; Zumbo G; Barcella W; Steeden JA; Muthurangu V; Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Kotecha T; Francis R; Rezk T; Quarta CC; Whelan CJ; Lachmann HJ; Wechalekar AD; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2019 May; 12(5):823-833. PubMed ID: 29680336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variations in the threshold's values for border zone and dense scar produce significant changes in the scar parameters obtained by ADAS-3D.
    Faga V; Dallaglio PD; Claver E; Rodriguez-García J; San Antonio R; Rodriguez M; Payan C; Comin-Colet J; Anguera I; Di Marco A
    Heart Rhythm; 2024 Jul; ():. PubMed ID: 38960303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of CMR and PET in Predicting Ventricular Arrhythmias in Ischemic Cardiomyopathy Patients Eligible for ICD.
    Rijnierse MT; van der Lingen ACJ; de Haan S; Becker MAJ; Harms HJ; Huisman MC; Lammertsma AA; van de Ven PM; van Rossum AC; Knaapen P; Allaart CP
    JACC Cardiovasc Imaging; 2020 Aug; 13(8):1755-1766. PubMed ID: 32305468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
    Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive Mapping of the Electrophysiological Substrate in Cardiac Amyloidosis and Its Relationship to Structural Abnormalities.
    Orini M; Graham AJ; Martinez-Naharro A; Andrews CM; de Marvao A; Statton B; Cook SA; O'Regan DP; Hawkins PN; Rudy Y; Fontana M; Lambiase PD
    J Am Heart Assoc; 2019 Sep; 8(18):e012097. PubMed ID: 31496332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial denervation coincides with scar heterogeneity in ischemic cardiomyopathy: A PET and CMR study.
    de Haan S; Rijnierse MT; Harms HJ; Verberne HJ; Lammertsma AA; Huisman MC; Windhorst AD; van Rossum AC; Allaart CP; Knaapen P
    J Nucl Cardiol; 2016 Dec; 23(6):1480-1488. PubMed ID: 26553060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
    Fontana M; Ćorović A; Scully P; Moon JC
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative tissue characterization of infarct core and border zone in patients with ischemic cardiomyopathy by magnetic resonance is associated with future cardiovascular events.
    Heidary S; Patel H; Chung J; Yokota H; Gupta SN; Bennett MV; Katikireddy C; Nguyen P; Pauly JM; Terashima M; McConnell MV; Yang PC
    J Am Coll Cardiol; 2010 Jun; 55(24):2762-8. PubMed ID: 20538171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive detection of cardiac involvement in patients with hereditary transthyretin associated amyloidosis using cardiac magnetic resonance imaging: a prospective study.
    Deux JF; Damy T; Rahmouni A; Mayer J; Planté-Bordeneuve V
    Amyloid; 2014 Dec; 21(4):246-55. PubMed ID: 25211144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scar channels in cardiac magnetic resonance to predict appropriate therapies in primary prevention.
    Sánchez-Somonte P; Quinto L; Garre P; Zaraket F; Alarcón F; Borràs R; Caixal G; Vázquez S; Prat S; Ortiz-Perez JT; Perea RJ; Guasch E; Tolosana JM; Berruezo A; Arbelo E; Sitges M; Mont L; Roca-Luque I
    Heart Rhythm; 2021 Aug; 18(8):1336-1343. PubMed ID: 33892202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transthyretin cardiac amyloidosis.
    Porcari A; Fontana M; Gillmore JD
    Cardiovasc Res; 2023 Feb; 118(18):3517-3535. PubMed ID: 35929637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CMR-based identification of critical isthmus sites of ischemic and nonischemic ventricular tachycardia.
    Piers SR; Tao Q; de Riva Silva M; Siebelink HM; Schalij MJ; van der Geest RJ; Zeppenfeld K
    JACC Cardiovasc Imaging; 2014 Aug; 7(8):774-84. PubMed ID: 25051947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular magnetic resonance determinants of ventricular arrhythmic events after myocardial infarction.
    Jáuregui B; Soto-Iglesias D; Penela D; Acosta J; Fernández-Armenta J; Linhart M; Ordóñez A; San Antonio R; Terés C; Chauca A; Carreño JM; Scherer C; Falasconi G; Prat-González S; Perea RJ; Mont L; Bosch X; Ortiz-Pérez JT; Berruezo A
    Europace; 2022 Jul; 24(6):938-947. PubMed ID: 34849726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scar border zone mass and presence of border zone channels assessed with cardiac magnetic resonance imaging are associated with ventricular arrhythmia in patients with ST-segment elevation myocardial infarction.
    Thomsen AF; Bertelsen L; Jøns C; Jabbari R; Lønborg J; Kyhl K; Göransson C; Nepper-Christensen L; Atharovski K; Ekström K; Tilsted HH; Pedersen F; Køber L; Engstrøm T; Vejlstrup N; Jacobsen PK
    Europace; 2023 Mar; 25(3):978-988. PubMed ID: 36576342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-Imaging Characterization of Cardiac Phenotype in Different Types of Amyloidosis.
    Ioannou A; Patel RK; Razvi Y; Porcari A; Knight D; Martinez-Naharro A; Kotecha T; Venneri L; Chacko L; Brown J; Manisty C; Moon J; Wisniowski B; Lachmann H; Wechelakar A; Whelan C; Kellman P; Hawkins PN; Gillmore JD; Fontana M
    JACC Cardiovasc Imaging; 2023 Apr; 16(4):464-477. PubMed ID: 36648052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality.
    Cardona A; Arnold WD; Kissel JT; Raman SV; Zareba KM
    J Cardiovasc Magn Reson; 2019 May; 21(1):26. PubMed ID: 31046780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.